Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I Study of MLN 9708 in Addition to Chemotherapy for the Treatment of Acute Lymphoblastic Leukemia in Older Adults

NCT02228772 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.

NCT NCT02228772
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02228772 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I Study of MLN 9708 in Addition to Chemotherapy for the Treatment of Acute Lymphoblastic Leukemia in Older Adults
Lead sponsor
Massachusetts General Hospital
Phase
Phase 1
Overall status
Completed
Start date
December 31, 2014
Completion date
November 30, 2019
Enrollment
19 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

acute lymphoblastic leukemia, b-cell adult acute lymphoblastic leukemia, lymphoblastic lymphoma, t-cell adult acute lymphoblastic leukemia